Why Neuromodulation Could Be the Future of Migraine Treatment
For decades, migraine treatment has followed the same predictable script: medications to stop attacks, medications to prevent them, and (if those fail) more medications to manage the side effects of the first ones. The market is dominated by triptans, CGRP monoclonal antibodies, and polypharmacy workarounds. But the underlying problem remains: many patients don’t respond, costs […]
Could Relivion® Cut Migraine’s Multi-Billion Dollar Burden?
A Closer Look at Cost Savings and Healthcare Economics Migraine isn’t just a headache—it’s a multi-billion dollar drain on healthcare systems and economies worldwide. In the U.S. alone, migraine costs are estimated at over $36 billion annually (1), driven by direct medical expenses, lost productivity, and frequent ER visits. Despite an explosion of new treatments […]
How Big Is the Migraine Market in the United States?
How Big Is the Migraine Market in the United States? If you’ve ever had a migraine, you know it’s not just a bad headache. It’s a full-body shutdown—pounding pain, nausea, light and sound sensitivity, sometimes even vision loss. It can wreck your whole day, if not your whole week. And if you get them often, […]
